Status:
UNKNOWN
Construction of a Prediction Model for Metachronous Colorectal Adenoma
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Conditions:
Metachronous Colorectal Adenoma
Eligibility:
All Genders
18-75 years
Brief Summary
The study aimed to explore the independent risk factors for the metachronous colorectal adenoma after endoscopic resection, and construct the prediction model of metachronous colorectal adenoma, in or...
Detailed Description
A large cohort of eligible patients were included in the analysis, and classified into derivation and validation cohorts at a ratio of 7:3. Demographic and clinicopathological characteristics of parti...
Eligibility Criteria
Inclusion
- Patients aged ≥18 and ≤75 years old. Patients with complete data on demography and clinicopathology.
Exclusion
- Patients with a history of inflammatory bowel disease, enterophthisis, familial adenomatous polyposis, P-J syndrome and intestinal lymphoma.
- Patients with a previous history of colorectal neoplasm. Patients with a history of severe systemic diseases. Lack of complete clinical data for analysis.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
30000 Patients enrolled
Trial Details
Trial ID
NCT05183438
Start Date
May 1 2021
End Date
December 1 2022
Last Update
January 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, China, 210029